The Disintegration of Soybean by a Cellulase Preparation from Irpex lacteus Fr. and the Enzyme Relating to It

It was found that there was a fairly well correlation between the soybean disintegrating activity (SD activity) of Driselase, a cellulase preparation from Irpex lacteus, and the improvement of feed efficiency caused from its supplementation to a ration.

When the seed coat of soybean was hydrolysed by Driselase, arabinose, galactose, and other aldoses were liberated; on the other hand, some ketoses such as fructose, sucrose, raffinose and such were detected as a result of the hydrolysis of the cotyledon. On the fractionation of Driselase with column chromatography, acid proteinase was appeared to be parallel, in a certain extent, with SD activity. These suggested that Driselase partially attacked the cell walls of the cotyledon and led to the leakage of intracellular substances such as ketoses and protein.

Since it was revealed, however, that only a kind of pectin hydrolase was detected in the fraction with high SD activity, the maceration of soybean by a pectin hydrolase was thought to be chiefly concerned with SD activity.     

A mushroom lectin from ascomycete Cordyceps militaris

A mushroom lectin has been purified from ascomycete Cordyceps militaris, which is one of the most popular mushrooms in eastern Asia used as a nutraceutical and in traditional Chinese medicine. This lectin, designated CML, exhibited hemagglutination activity in mouse and rat erythrocytes, but not in human ABO erythrocytes. SDS-PAGE of CML revealed a single band with a molecular mass of 31.0 kDa under both nonreducing and reducing conditions that was stained by silver nitrate, and a 31.4 kDa peak in a Superdex-200 HR gel-filtration column. The hemagglutination activity was inhibited by sialoglycoproteins, but not in by mono- or disaccharides, asialoglycoproteins, or de-O-acetylated glycoprotein. The activity was maximal at pH 6.0–9.1 and at temperatures below 50 °C. Circular dichroism spectrum analysis revealed that CML comprises 27% α-helix, 12% β-sheets, 29% β-turns, and 32% random coils. Its binding specificity and secondary structure are similar to those of a fungal lectin from Arthrobotrys oligospora. However, the N-terminal amino acid sequence of CML differs greatly from those of other lectins. CML exhibits mitogenic activity against mouse splenocytes.     

Structural characterization and antioxidant activity of a polysaccharide from the fruiting bodies of cultured Cordyceps militaris

The water-soluble crude polysaccharides were obtained from the fruiting bodies of cultured Cordyceps militaris by hot water extraction followed by ethanol precipitation. The polysaccharides were successively purified by chromatography on DEAE–cellulose-52 and Sephacryl S-100 HR columns, giving main three polysaccharide fractions termed P50-1, P70-1, and P70-2. Structural features of P70-1 were investigated by a combination of chemical and instrumental analysis, such as partial acid hydrolysis, methylation analysis, periodate oxidation – Smith degradation, GC–MS, ¹³C NMR, HPAEC-PAD, and FT-IR. The results indicated that P70-1 has a backbone of (1 → 6)-linked β-d-mannopyranosyl residues, which occasionally branches at O-3. The branches were mainly composed of (1 → 4)-linked -d-glucopyranosyl and (1 → 6)-linked β-d-galactopyranosyl residues, and terminated with β-d-galactopyranosyl residues and -d-glucopyranosyl residues. In the in vitro antioxidant assay, P70-1 was found to possess hydroxyl radical-scavenging activity with an IC₅₀ value of 0.548 mg/ml.     

虫草对肺部疾病治疗的研究进展

肺纤维化、慢性阻塞性肺病和哮喘是人类主要的呼吸系统疾病,它们均以肺部或呼吸道的慢性炎症为特征,当前的治疗方法尚不理想并伴随着很多的副作用,人们迫切需要一种更安全的替代疗法。冬虫夏草是我国传统的名贵药用真菌,被广泛用来治疗多种肺部疾病。近年来,冬虫夏草对肺部疾病治疗作用的研究取得了较大进展,本文综述了冬虫夏草、其无性型中国被毛孢(Hirsutella sinensis或Ophicordyceps sinensis)和其他相关虫草及其提取物对肺纤维化、慢性阻塞性肺病、哮喘等肺部疾病治疗作用的研究进展,并介绍了其作用机制的研究成果。     

Anti-HCV activity of the Chinese medicinal fungus Cordyceps militaris

Persistent hepatitis C virus (HCV) infection causes chronic liver diseases and is a global health problem. Although the sustained virologic response rate in the treatment of genotype 1 using new triple therapy (pegylated-interferon, ribavirin, and telaprevir/boceprevir) has been improved by more than 70%, several severe side effects such as skin rash/ageusia and advanced anemia have become a problem. Under these circumstances, a new type of anti-HCV oral drug with few side effects is needed. Our recently developed HCV drug assay systems, including the HuH-7 cell line-derived OR6 and AH1R, and the Li23 cell line-derived ORL8 and ORL11, allow genome-length HCV RNAs (several strains of genotype 1b) encoding renilla luciferase to replicate efficiently. Using these systems as anti-HCV candidates, we have identified numerous existing medicines that can be used against HCV with few side effects, such as statins and teprenon. To obtain additional anti-HCV candidates, we evaluated a number of oral health supplements, and found that the capsule but not the liquid form of Cordyceps militaris (CM) (Ascomycotinanorth, North Chinese caterpillar fungus), which is used as a Chinese herbal medicine, exhibited moderate anti-HCV activity. In combination with interferon-α or ribavirin, CM exhibited an additive inhibitory effect. Among the main components of CM, cordycepin, but not ergosterol, contributed to the anti-HCV activity of CM. In consideration of all these results, we suggest that CM would be useful as an oral anti-HCV agent in combination with interferon-α and/or ribavirin.     

蛹虫草病原真菌虫草生齿梗孢Calcarisporium cordycipiticola的生物学特性研究

蛹虫草已经成为我国乃至东南亚地区极其重要的食药用真菌,虽然其子实体已经实现规模化生产,但在产业发展中遇到许多问题,真菌病害为其中之一,如引起蛹虫草“白毛病”病害的虫草生齿梗孢Calcarisporium cordycipiticola。本研究以虫草生齿梗孢为对象,研究了其生物学特性、发病特性及侵染特点。结果表明：该病原菌菌丝分枝较多,短时间内产生大量分生孢子;最适生长温度为25℃,此温度有利于该病害快速传播;其分生孢子比蛹虫草分生孢子耐紫外能力强。栽培过程中该病害多发生在蛹虫草生长发育后期,可以侵染培养基表面、子实体底部、中部和顶端等各个部位。人工接种发现该病原菌可以侵染蛹虫草生长发育的任意阶段,后期子实体被白毛覆盖。对峙实验发现虫草生齿梗孢菌丝逐渐生长到蛹虫草菌丝上,但未发现两菌丝互相缠绕的现象。对该病原菌基本生物学研究,将为建立该病害的早期检测及预防方法提供依据。     

蛹虫草黄色素提取工艺优化及其体外抗氧化研究

本研究为了得到蛹虫草黄色素最佳提取工艺,采用Box-Behnken方法,在单因素试验的基础上以黄色素的提取率为响应值,利用响应面设计对超声波辅助乙醇提取蛹虫草黄色素工艺进行优化,并对其体外抗氧化活性进行了研究。结果表明超声波辅助乙醇提取蛹虫草黄色素的最佳工艺条件为乙醇体积分数57.00%、液料比32.00:1、提取时间18.00min,在此条件下黄色素提取率达(1.976±0.017)mg/g。红外光谱和高效液相色谱的结果表明,该提取条件下获得的蛹虫草黄色素主要成分为cordyxanthin。蛹虫草黄色素DPPH自由基清除力IC₅₀为0.59mg/mL,在5mg/mL时,总抗氧化力高达0.587,在10mg/mL时,铁离子还原力高达1.488。     

冬虫夏草菌药理功能研究进展

名贵药用菌冬虫夏草有十分广泛的药理活性 ,可用于高血糖、高血脂、呼吸系统疾病和肾衰的治疗。近来的研究显示冬虫夏草可用于自体免疫系统疾病和癌症的治疗。冬虫夏草的研究正在迅速取得许多新进展。     

培养基成分对提高虫草菌素含量的影响(英文)

以蛹虫草 (Cordycepsmilitaris)的无性形Peacilomycesmilitaris 97- 0 70 6为材料 (以下简称 0 70 6菌株 ) ,研究提高其主要活性成分———虫草菌素 (cordycepin)含量的培养基成分。结果表明 ,最好的一个培养基配比可将 0 70 6菌株的虫草菌素含量提高到 1 2 1% ,比用Czapek培养基 (CK)发酵得到的 0 15 %提高 8 1倍。为进一步提高虫草菌素含量奠定了基础。 0 70 6菌株接种于PDA斜面 ,2 7℃ ,7d ,活化 3次 ,然后接种于蛋白胨 2 0 0 %、蔗糖 2 0 0 %、MgSO4·7H2 O 0 0 5 %、KH2 PO40 10 %的液体母种培养基中 ,14 0r/min ,2 7℃ ,摇瓶培养 84h ,再将液体母种以 5 0 0 %的种子量接入蛋白胨 2 0 0 %、酵母膏 3 0 0 %、麦芽糖 3 0 0 %、蔗糖4 0 0 %、KH2 PO40 10 %、NH4Cl0 2 0 %、MgSO40 0 5 %的培养基中 ,14 0r/min ,2 7℃摇瓶培养 192h ,得 0 70 6菌株的虫草菌素含量为 1 2 1%。     

冬虫夏草研究进展

综述了近几年来我国对冬虫夏草 [Cordycepssinensis(Berk)Sacc .]的无性型鉴定、人工培养、深层发酵、化学成分分析、药理及临床应用等方面的研究进展。